摘要

Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and is independently associated with poor cardiovascular outcomes. However, the direct relationship between serum ADMA level and the extent of subclinical coronary atherosclerotic plaque has never been investigated. In total, 130 consecutive asymptomatic Taiwanese subjects (mean age, 55.6±10 years), who received a health screening evaluation, were enrolled. Coronary plaque detected by computed tomography coronary angiography (CTCA) was observed in 85 (65.4%) of 130 individuals. Patients with coronary plaque had a higher ADMA level (1.16±1.15 μmol/L vs. 0.42 ± 0.33 μmol /L, p
原文英語
頁(從 - 到)236-243
頁數8
期刊Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry
12
發行號3
DOIs
出版狀態已發佈 - 2012

ASJC Scopus subject areas

  • 內分泌學、糖尿病和代謝
  • 免疫學和過敏
  • 藥理

指紋

深入研究「The association between serum asymmetric dimethylarginine and coronary atherosclerotic plaque in an asymptomatic population」主題。共同形成了獨特的指紋。

引用此